Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial
- Resource Type
- Article
- Source
- The Lancet Respiratory Medicine; 20230101, Issue: Preprints
- Subject
- Language
- ISSN
- 22132600; 22132619